# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Immune thrombocytopenia

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 69 results.
Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children
Status: Recruiting
Last Changed: Feb 21, 2020
First Received: May 07, 2019
Disease(s): Immune Thrombocytopenia
Intervention(s): Eltrombopag, Steroids, IVIG, Rho(D) Immune Globulin
Locations: Phoenix CHildren's Hospital, Phoenix, Arizona, United States
Arkansas Children's Hospital, Little Rock, Arkansas, United States
UCSF Benioff Children's Hospital, San Francisco, California, United States
University of Florida College of Medicine, Gainesville, Florida, United States
Riley Hospital for Children-Indiana University, Indianapolis, Indiana, United States
... and 7 other locations.
Response Rate and Duration After Discontinuation Thrombopoietin Receptor Agonists Primary Immune Thrombocytopenia
Status: Recruiting
Last Changed: Oct 23, 2018
First Received: Nov 21, 2014
Disease(s): Immune Thrombocytopenia
Intervention(s): Eltrombopag, Romiplostin
Locations: S.O.C. di Medicina Interna B - Ospedale - Cardinal Massaia di Asti, Asti, Italy
Istituto di Ematologia "Lorenzo e A. Seragnoli", Bologna, Italy
Unità di Onco-Ematologia - Azienda Ospedaliera - Garibaldi, Catania, Italy
Unità di Ricerca e di Malattie del sangue - Ematologia San Luca Vecchio Pad. 16 - 1° Piano, Firenze, Italy
Clinica Medica III - Padiglione ex isolamento - Azienda Ospedale Università San Martino, Genova, Italy
... and 9 other locations.
Risk Factors for Thrombosis in Immune Thrombocytopenia
Status: Recruiting
Last Changed: Apr 26, 2019
First Received: Jan 29, 2019
Disease(s): Immune Thrombocytopenia
Locations: University Hospital Toulouse, Toulouse, France
A Study to Assess the Efficacy, Safety, and Tolerability of Rozanolixizumab in Adult Study Participants With Persistent or Chronic Primary Immune Thrombocytopenia (ITP)
Status: Not yet recruiting
Last Changed: Jan 13, 2020
First Received: Jan 13, 2020
Disease(s): Primary Immune Thrombocytopenia
Intervention(s): Rozanolixizumab, Placebo
Phase II Trial of Romiplostim With Danazol in Patients With Eltrombopag-resistant Immune Thrombocytopenia
Status: Not yet recruiting
Last Changed: Feb 28, 2020
First Received: Feb 28, 2020
Disease(s): Immune Thrombocytopenia
Intervention(s): Romiplostim and danazol
Connection Between Vitamin D Level and the Efficacy of Dexamethasone in Immune Thrombocytopenia
Status: Not yet recruiting
Last Changed: Apr 10, 2020
First Received: Mar 24, 2020
Disease(s): Immune Thrombocytopenia
Intervention(s): Dexamethasone
The Combination of ATRA and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia
Status: Recruiting
Last Changed: Jan 22, 2020
First Received: Jan 03, 2020
Disease(s): Immune Thrombocytopenia
Intervention(s): Dexamethasone, ATRA
Locations: Peking University Insititute of Hematology, Peking University People's Hospital, Beijing, Beijing, China
Role of Fcgamma Receptors in Immune Thrombocytopenia (ITP)
Status: Recruiting
Last Changed: Mar 09, 2018
First Received: Jul 01, 2016
Disease(s): Immune Thrombocytopenia
Intervention(s): blood sample, spleen sample
Locations: CHU Dijon Bourgogne, Dijon, France
Study of Oral SKI-O-703, SYK Inhibitor, in Patients With Persistent and Chronic Immune Thrombocytopenia (ITP)
Status: Recruiting
Last Changed: Mar 04, 2020
First Received: Aug 14, 2019
Disease(s): Immune Thrombocytopenia
Intervention(s): SKI-O-703, Placebo oral tablet
Locations: University of Southern California, 1441 Eastlake Ave., Los Angeles, California, United States
Duke University Medical Center, 2301 Erwin Road, Durham, North Carolina, United States
University General Hospital of Patras, Department of Internal Medicine, Hematology Division, Rio Patra, Patras, Achaia, Greece
Laiko General Hsoptial of Athens, 16 Sevastoupoleos Street, Athens, Attiki, Greece
University Hospital of Larissa, Mezourlo, Larissa, Greece
... and 19 other locations.
The Combination of Atorvastatin, Acetylcysteine and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
Status: Not yet recruiting
Last Changed: Mar 09, 2018
First Received: Mar 09, 2018
Disease(s): Immune Thrombocytopenia
Intervention(s): atorvastatin, Acetylcysteine, Danazol
Locations: Peking University Insititute of Hematology, Peking University People's Hospital, Beijing, Beijing, China